Cargando…

Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy

Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers in the human population. Different etiological factors such as hepatitis B and C virus, alcohol and diabetes cause liver injury followed by inflammation, necrosis and hepatocytes proliferation. Continuous cycles of this de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tahmasebi Birgani, Maryam, Carloni, Vinicio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343939/ https://www.ncbi.nlm.nih.gov/pubmed/28216578 http://dx.doi.org/10.3390/ijms18020405

Ejemplares similares

The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis
por: Shahrisa, Arman, et al.
Publicado: (2021)

The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma
por: Rombouts, Krista, et al.
Publicado: (2013)

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
por: Li, Zishuai, et al.
Publicado: (2023)

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
por: Oura, Kyoko, et al.
Publicado: (2021)

Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
por: Wu, Qin, et al.
Publicado: (2019)

HOTAIR: A Promising Long Non-coding RNA with Potential Role in Breast Invasive Carcinoma
por: Avazpour, Niloofar, et al.
Publicado: (2017)

Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment
por: Mroweh, Mariam, et al.
Publicado: (2021)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022)

The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma
por: Oura, Kyoko, et al.
Publicado: (2023)

Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy
por: Li, Hanmin, et al.
Publicado: (2016)

Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis?
por: Bizzarri, Mariano, et al.
Publicado: (2014)

The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance
por: Carloni, Vinicio, et al.
Publicado: (2022)

The Tumor Microenvironment: The Making of a Paradigm
por: Witz, Isaac P.
Publicado: (2009)

The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
por: Volponi, Camilla, et al.
Publicado: (2022)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
por: Hadiloo, Kaveh, et al.
Publicado: (2023)

Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Lv, Yue, et al.
Publicado: (2023)

New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
por: Jin, Xin, et al.
Publicado: (2022)

DNA vaccine containing Flagellin A gene induces significant immune responses against Helicobacter pylori infection: An in vivo study
por: Ansari, Hossein, et al.
Publicado: (2021)

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
por: Lu, Chen, et al.
Publicado: (2019)

Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
por: Macek Jilkova, Zuzana, et al.
Publicado: (2019)

The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Kaiting, et al.
Publicado: (2022)

Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
por: Sas, Zuzanna, et al.
Publicado: (2022)

Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Lu, Yuanfei, et al.
Publicado: (2022)

Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
por: Kudo, Masatoshi
Publicado: (2021)

miR-155 rs767649 T>A gene polymorphism is associated with downregulation of miR-155 expression, suppressor of cytokine signaling-1 overexpression, and low probability of metastatic tumor at the time of breast cancer diagnosis
por: Iranparast, Sara, et al.
Publicado: (2023)

Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
por: Carloni, Riccardo, et al.
Publicado: (2023)

Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
por: Chew, Valerie, et al.
Publicado: (2012)

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2021)

Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma
por: Chen, Quan, et al.
Publicado: (2021)

Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
por: Morita, Masahiro, et al.
Publicado: (2023)

Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Tian, Zongbiao, et al.
Publicado: (2020)

Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2023)

Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review
por: Li, Yunheng, et al.
Publicado: (2022)

The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
por: Capece, Daria, et al.
Publicado: (2013)

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
por: Chen, Ruyin, et al.
Publicado: (2022)

Impact of Prolonged Fraction Delivery Time Modelling Stereotactic Body Radiation Therapy with High Dose Hypofractionation on the Killing of Cultured ACHN Renal Cell Carcinoma Cell Line
por: Khorramizadeh, M., et al.
Publicado: (2017)

Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment
por: Jia, Qingan, et al.
Publicado: (2021)

Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Nevarez, Nicole M, et al.
Publicado: (2021)

Role of Periostin in Hepatocellular Carcinoma: The Importance of Tumor Microenvironment
por: Lee, Jung Il
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3jb5l3rt2mvnlnhtv7aq725fp6